Thank you for visiting our website. Our office is beginning to reopen, although our home office in San Bernardino is not fully staffed. The home office is open Monday – Thursday each week, and some Fridays We have employees working from home to answer your questions and our Consultants are available, as always. We are still conducting live webinars; please check the listings for dates and times. Please contact us at help@corcoranccg.com or leave a voicemail at (800) 399-6565. We will respond to your inquiries as soon as possible.


CXL wins FDA approval, so prepare to code – Ophthalmology Management

Corneal collagen cross-linking is a fairly new procedure to treat certain corneal diseases. As is often the case, there are lots of questions about coverage from third-party payers at this point.

This article addresses the following questions:

  • What is corneal collagen cross-linking?
  • What conditions are treated with CXL?
  • Has CXL been approved by the FDA?
  • What CPT code describes CXL?
  • Is CXL covered by Medicare or health insurance?
  • If coverage of CXL is unlikely or uncertain, how should we proceed?

This article was published in Ophthalmology Management’s Coding & Reimbursement column, which is written by Corcoran’s Executive Vice-President, Suzanne Corcoran, COE. To view the entire article in Ophthalmology Management, click on the link below:

http://www.ophthalmologymanagement.com/articleviewer.aspx?articleID=114345

Related Posts

Website by MIC